ID

24554

Beschrijving

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Trefwoorden

Versies (2)
  1. 30-07-17 30-07-17 -
  2. 06-08-17 06-08-17 -
Geüploaded op

6 augustus 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT COMPLIANCE NCT00079911

Engels

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT COMPLIANCE NCT00079911

1 Formulieren  
Study administration
Beschrijving

Study administration

Subject Identifier
Beschrijving

Subject Identifier

Datatype

integer

Alias
UMLS CUI [1]
C2348585
INVESTIGATIONAL PRODUCT COMPLIANCE
Beschrijving

INVESTIGATIONAL PRODUCT COMPLIANCE

Investigational Product
Beschrijving

Check carefully for any overlapping start/stop date. Ensure any deviations from investigational product are recorded correctly as outlined in the study protocol. Record a new start and stop date if greater than or equal to one day of dosing is missed.

Datatype

integer

Alias
UMLS CUI [1]
C0304229
Date Investigational Product Dispensed
Beschrijving

dispension date

Datatype

date

Maateenheden
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1115441
DD/MMM/YY
Date Investigational Product Returned
Beschrijving

date product returned

Datatype

date

Maateenheden
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C2826249
DD/MMM/YY
Number of Tablets/Caplets Dispensed
Beschrijving

dispensed amount

Datatype

integer

Alias
UMLS CUI [1]
C0805077
Number of Tablets/Caplets Returned
Beschrijving

returned amount

Datatype

integer

Alias
UMLS CUI [1]
C2699071
Terug naar het begin van de pagina

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT COMPLIANCE NCT00079911

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT COMPLIANCE
Item
Investigational Product
integer
C0304229 (UMLS CUI [1])
Investigational Product
Code List
Investigational Product
CL Item
Double-Blind therapy (23)
CL Item
Open-label treatment (24)
dispension date
Item
Date Investigational Product Dispensed
date
C0013230 (UMLS CUI [1,1])
C1115441 (UMLS CUI [1,2])
date product returned
Item
Date Investigational Product Returned
date
C0013230 (UMLS CUI [1,1])
C2826249 (UMLS CUI [1,2])
dispensed amount
Item
Number of Tablets/Caplets Dispensed
integer
C0805077 (UMLS CUI [1])
returned amount
Item
Number of Tablets/Caplets Returned
integer
C2699071 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial